Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study.
Bonaventura A, Grossi F, Carbone F, Vecchié A, Minetti S, Bardi N, Elia E, Ansaldo AM, Ferrara D, Rijavec E, Dal Bello MG, Rossi G, Biello F, Tagliamento M, Alama A, Coco S, Spallarossa P, Dallegri F, Genova C, Montecucco F. Bonaventura A, et al. Among authors: dallegri f. Cancer Immunol Immunother. 2019 Aug;68(8):1351-1358. doi: 10.1007/s00262-019-02367-z. Epub 2019 Jul 20. Cancer Immunol Immunother. 2019. PMID: 31327024 Free PMC article.
Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment.
Bonaventura A, Grossi F, Carbone F, Vecchié A, Minetti S, Bardi N, Elia E, Ansaldo AM, Ferrara D, Rijavec E, Dal Bello MG, Rossi G, Biello F, Tagliamento M, Alama A, Coco S, Spallarossa P, Dallegri F, Genova C, Montecucco F. Bonaventura A, et al. Among authors: dallegri f. Clin Transl Oncol. 2020 Sep;22(9):1603-1610. doi: 10.1007/s12094-020-02305-x. Epub 2020 Feb 11. Clin Transl Oncol. 2020. PMID: 32048158
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer.
Carbone F, Grossi F, Bonaventura A, Vecchié A, Minetti S, Bardi N, Elia E, Ansaldo AM, Ferrara D, Rijavec E, Dal Bello MG, Biello F, Rossi G, Tagliamento M, Alama A, Coco S, Spallarossa P, Dallegri F, Genova C, Montecucco F. Carbone F, et al. Among authors: dallegri f. Clin Exp Metastasis. 2019 Oct;36(5):449-456. doi: 10.1007/s10585-019-09984-z. Epub 2019 Aug 2. Clin Exp Metastasis. 2019. PMID: 31376097 Clinical Trial.
Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes.
Liberale L, Montecucco F, Casetta I, Seraceni S, Trentini A, Padroni M, Dallegri F, Mach F, Fainardi E, Carbone F. Liberale L, et al. Among authors: dallegri f. Eur J Clin Invest. 2016 Dec;46(12):1053-1062. doi: 10.1111/eci.12692. Epub 2016 Nov 10. Eur J Clin Invest. 2016. PMID: 27759884
Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis.
Carbone F, Rigamonti F, Burger F, Roth A, Bertolotto M, Spinella G, Pane B, Palombo D, Pende A, Bonaventura A, Liberale L, Vecchié A, Dallegri F, Mach F, Montecucco F. Carbone F, et al. Among authors: dallegri f. Int J Cardiol. 2018 Mar 15;255:195-199. doi: 10.1016/j.ijcard.2018.01.008. Epub 2018 Jan 5. Int J Cardiol. 2018. PMID: 29317141
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases.
Carbone F, Bodini G, Brunacci M, Bonaventura A, Vecchiè A, Liberale L, Crespi M, Baldissarro I, Dallegri F, Savarino V, Montecucco F, Giannini EG. Carbone F, et al. Among authors: dallegri f. Eur J Clin Invest. 2018 Oct;48(10):e13002. doi: 10.1111/eci.13002. Epub 2018 Aug 6. Eur J Clin Invest. 2018. PMID: 30011062
277 results